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A new the oxidative derivatization method by means of peroxoacid for the indirect 
spectrophotometric determination of Periciazine is presented. A potassium 
hydrogenperoxymonosulfateas a derivatizing agent for Periciazine, yielding the absorbative 
Periciazine sulfoxide at λmaх=362 nm is proposed. This reaction product was successfully employed 
for spectrophotometric determination of the Periciazine. The UV spectrophotometric determination 
of the Periciazine as its sulfoxide proved to be the more simple and selective method. Limit of 
quantification (LOQ=10S) is 2.8 µg·mL-1. The common excipients employed do not interfere in the 
determination of phenothiazine drug. Results of analysis of the drug dosage forms by the proposed 
method are in good agreement with those of the official method. RSD=1.76 % (δ <RSD). 
________________________________________________________________________________ 
Introduction 
Periciazine (Synonyms: Pericyazine, 
ProPericiazine (PCZ), Neuleptil, Neulactil,) 
chemically, 3‐cyano‐10 (3‐4'‐hydroxy 
piperidinopropyl) phenothiazine or 10-[3-(4-
Hydroxypiperidino)propyl]phenothiazine-2-
carbonitrile; 1-[3-(2-Cyanophenothiazin-10-
yl)propyl]piperidin-4-ol; (Figure 1)is usually 
given as the base but the mesilate and tartrate 
have also been used; a synthetic piperidine 
phenothiazine derivative with general properties 
similar to those of chlorpromazine. It is used in 
the treatment of psychoses including 
schizophrenia and disturbed behavior, and in the 
short-term management of severe anxiety [1,2]. 
Periciazine is a phenothiazine derivative used for 
the treatment of people with schizophrenia and is 
reputed to have a low level of extrapyramidal 
adverse effects. 
Very few analytical methods have been 
reported with Periciazine individually and along 
with other drugs. Among that there is 
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spectrophotometric method based on the 
development of red colored products by the 
interaction of phenothiazines with 
diazotisedanthranilic acid in hydrochloric acid 
medium. 
S
N CN
N
OH
 
Figure 1. Chemical structure of Periciazine base 
The reaction proceeds via the oxidation of 
the phenothiazine nucleus into a semiquinonoid 
radical [3].Flow-injection procedure of the 
spectrophotometric determination of Periciazine 
based on its the oxidation reaction by means of 
Fe(III) and K3[Fe(CN)6 [4], differential pulse and 
square wave voltammetric methods [5] and 
refractometry [6] have beenalready reported. 
Several chromatographic methods have been 
published for the determination of Periciazine in 
bulk or in different pharmaceutical formulations 
as in biological ﬂuids as well. A high-
performance liquidchromatographic method 
(HPLC) has been developed for the simultaneous 
analysis of the Periciazine and another 
phenothiazines in human serum using 
spectrophotometric detection [7]. A highly 
sensitive liquid chromatography–tandem mass 
spectrometry method was developed for the 
determination of Periciazine in the presence of 7-
hydroxy and sulphoxide metabolites of 
Periciazine in human plasma after liquid-liquid 
extraction with ethyl acetate [8]. The 
chromatographic behavior of phenothiazine 
derivatives was studied by thin-layer 
chromatography with the use of Sorbfil silica gel 
plates in a binary benzene-methanol mixture of 
solvents [9]. A chromatographic conditionswere 
optimized and thin-layer chromatography 
method for determination of phenothiazine 
derivatives was described. Chromatographic 
systems with different polarity eluents in the 
wide composition range for screening of 
phenothiazine derived was studied [10]. 
The official compendia USP-39 [11] and 
Ph Eur. 9 [12] for the determination of 
phenothiazines in bulk, or in pharmaceutical 
formulations involves measurements of the 
absorbance at selected wavelengths, 
potentiometric titration in a non-aqueous 
medium and also HPLC method for estimation of 
API content in pharmaceutical preparations. 
HPLC technique, though selective and 
sensitive, is relatively expensive involving costly 
instruments and solvents. 
The main disadvantage of direct 
spectrophotometry in UV region is the sensitivity 
to excipients usually presented in pharmaceutical 
preparations. The descriptions given in the 
presented review methods, based on their 
oxidation reaction, can be alternatives. The 
absorbance of phenothiazine sulphoxides is less 
liable to spectral interferences from others 
ingredients of pharmaceuticals [13]. The 
described methods offer advantages in their 
simplicity, rapidity and common access to 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2019, VOLUME 07, ISSUE 02)  
54 
 
instrumentation. There are only a few methods 
based on the UV-absorption spectra of 
phenothiazines for their determination (e.g. on 
the absorption measurements in the methanol 
solution). The methods may be recommended as 
alternatives to the official methods. 
The purpose of the work was to develop a 
new analytical method for the quantitative 
determination of Periciazine in dosage forms in 
the presence of inactive ingredients by indirect 
absorption optical spectrophotometry in the form 
of a respective sulfoxide produced with 
potassium hydrogen peroxymonosulfate as an 
oxidant. 
Based on the results of the comparative 
study of the electron spectra of light absorption 
of solutions of Periciazine and its S-oxidation 
product with hydrogen peroxymonosulfate in 
acidic media, we proposed a selective method for 
spectrophotometric determination of Periciazine 
in 10 mg capsules and in a 4% solution (drops) 
for intravenous use. 
 
Experimental part 
Apparatus 
Registration of spectra of Periciazine 
solutions and products of its chemical oxidation, 
as well as measurement of absorbance of 
solutions, were carried out in a 1 cm thick quartz 
cuvette on an Evolution 60S UV-Visible 
Thermo-Scientific Spectrophotometer (USA) 
against a solution without the studied 
phenothiazine derivative or double-distilled 
water (compensation solution). 
The subject of the test was the finished 
form of the well-known drug Neuleptil®, 10 mg 
capsules No. 5, manufactured by SANOFI 
Famarella Chea Services Madrid S.A.U., Spain, 
number 17N0020 series. One capsule of 
Neuleptil contains 10 mg of Periciazine active 
ingredient, as well as inactive ingredients such as 
magnesium stearate (3 mg) and calcium 
hydrogen phosphate dihydrate (137 mg). As part 
of the capsule itself, there are such chemicals as 
gelatin and titanium dioxide. According to the 
analysis certificate, the average content of the 
drug (Periciazine base) was 10.07 mg in one 
capsule (limits - not less than 9.50 and not more 
than 10.50 mg to one capsule, that is 95-105%). 
Neuleptil, a 30 mL 4% oral (solution) 
drops containing 4 g of the Periciazine active 
ingredient, and also inactive ingredients such as 
purified water (100 mL), glycerol (15 g), 
ascorbic acid (0.8 g), ether oil, peppermint leaf 
extract (0.04 g), saccharose (sucrose) (25 g) and 
E150d (caramel, 0.2 g), tartaric acid (1.65 g) and 
96% ethanol (9.74 g). SANOFI - AVENTIS 
FRANCE (France), produced by A. 
Hutterman&Sie, GmbH, Germany. 
According to the Certificate of Analysis 
(series No. 6K0331), the average content of the 
drug (Periciazine active substance) was 3.96% in 
one capsule (limits of not less than 3.8 and not 
more than 4.2%, that is 95-105%). 
Reagents 
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In this experiment, the oxidation of a 
Periciazine to a S-oxide Periciazine using a 
potassium triple salt containing potassium 
peroxymonosulfate (KHSO5), potassium 
hydrogensulfate (KHSO4), and potassium 
sulfate (K2SO4) in a 2:1:1 molar ratio was 
realized. This product is sold under the trade 
name Oxone®Its formula weight is 614.8. 
Moreover, it is considered as “green” oxidizing 
agent because it has not toxic effects. 
Preparation of 0.005 mol L-1 potassium 
hydrogen peroxymonosulfate solution. About 
0.15-0.2 g of Oxone® was dissolved in 100 mL 
of double-distilled water. The content of 
potassium hydrogen peroxymonosulfate was 
determined by iodometric titration. 
Working Standard solution (WSS) of 
Periciazine  
 The working standard Periciazine 
solution, 0.10 mgmL-1, is prepared by volume-
weight method. A weighted amount of substance 
powder with a known content of the active 
substance containing 10.0 mg of Periciazine, 
recalculation on the Periciazine base 
(C21H23N3OS), is dissolved in 100.0 mL of a 
0.02 mol L-1hydrochloric acid solution at +20°C. 
Procedures 
Preparation of calibration graph 
An accurately measured by means of 
microburette, aliquot volumes of 2.5; 5; 10; 15; 
20 mL of Periciazine WSS are transfered in 50 
mL volumetric flasks. After that, 5 mL of 0.2 mol 
L-1hydrochloric acid and 20 mL of a 0.005 mol 
L-1 potassium hydrogen peroxymonosulfate 
solution were successively added. Then, it was 
necessary to shake thoroughly and bring the 
volume of the solution to the mark with double-
distilled water and close the flask and mix 
thoroughly. The solutions are measured at an 
analytical wavelength of 362 nm. Double-
distilled water as a compensating solution was 
used. 
Procedure for Pharmaceutical 
Preparations 
 Method for Periciazine content 
determination in 10 mg capsules. An accurately 
weighed amount of about 0.150 g of powder 
containing capsules (10 mg) corresponding to 
the average weight of the capsule is mixed with 
50 mL of a 0.2 mol L-1 solution of hydrochloric 
acid and shaken thoroughly for 30 min, filtered 
through a "yellow tape" filter, the residue is 
thoroughly rinsed on filter (3 times, 10 mL) with 
double-distilled water. Combine the filtrate, 
quantitatively transfer the solution to a 100 mL 
volumetric flask. The volume of the solution to 
the mark is adjusted with double-distilled water 
and mixed thoroughly. Take 20 mL of the 
Periciazine solution obtained by pipette and 
transfer to a 50 mL volumetric flask, add 5 mL 
of a 0.2 mol L-1 solution of hydrochloric acid and 
20.0 mL of 0.005 mol L-1 potassium hydrogen 
peroxymonosulfate solution, carefully shake and 
bring the solution to the mark with double-
distilled water, close the flask and mix 
thoroughly 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2019, VOLUME 07, ISSUE 02)  
56 
 
Similar procedures wereperformed with 
a standard solution was carried out.In this case, 
a volume of 20 mL of Periciazine solution were 
taken with pipette and transferred to a 50 mL 
volumetric flask together with 5 mL of 0.2 mol 
L-1 solution of hydrochloric acid and 20.0 mL of 
a 0.005 mol L-1potassium hydrogen 
peroxymonosulfate solution.Resulting solution 
was carefully shaked and the volume of the 
solution was filled to the mark with double-
distilled water. Finally, the flask was closedand 
mixed thoroughly. The solution was measured at 
an analytical wavelength of 362 nm in a 1 cm 
thick quartz cuvette against the double-distilled 
water as a compensating solution. 
The content of Periciazine, in calculation 
on Periciazine base (C21H23N3OS), in mg in one 
capsule, (X) is calculated by the equation 1:  
Х = ஼ೞ೟×஺ೣ×ଵ଴଴×௠ഥ
஺௦௧ ×௠
  (1) 
where Ахisoptical density in an experiment with 
a solution of capsules, 
Ast–represents an optical density of the solution 
in the experiment with the Periciazine WSS; 
С௦௧iscontent of Periciazine active substance in 
WSS, mgmL-1; mis weight of the powder 
contained in the capsules, g; 100 – volume of the 
volumetric flask, taken for the WSS or drug 
preparation; 
𝑚ഥ represents average weight of the capsule 
content, g. 
Method of determining the content of Periciazine 
in a solution  
An accurately measured volume of 
0.5 mL of solution was transferred to a 200 mL 
volumetric flask. The solution was diluted to 200 
mL with 50% solution of ethanol. The flask was 
closed and mixed thoroughly. 
Using a pipette, a volume of 5.00 mL of 
resulting Periciazine solution was transferred 
into 50 mL volumetric flask with 5 mL of 0.1 
mol L-1 solution of sulfuric acid and 10.0 mL of 
0.005 mol L-1 potassium hydrogen 
peroxymonosulfate solution. Finally, the volume 
of the solution was filled to the mark using 
double-distilled water, closed and mixed 
thoroughly. The solution was measured at 
wavelength 362 nm. 
Into another 50 mL volumetric flask, 
successively 5.00 mL of pre-diluted (1:400) 4% 
(40 mg to 1.00 mL) Neuleptil solution, 5.00 mL 
of 0.10 mg mL-1 of Periciazine WSS, 5 mL of 
0.1 mol L-1 solution of sulfuric acid and 20 mL 
of 0.005 mol L-1 potassium hydrogen 
peroxymonosulfate solution were mixed, bring 
the volume of the solution to the mark with 
double-distilled water, close and mix 
thoroughly. The solution was measured at 
wavelength 362 nm. 
The content of Periciazine, in calculation 
on Periciazine base (C21H23N3OS) in mg in one 
capsule (X) is calculated by theequation 2:  
Х = ஼ೌ×஺ೣ×ସ଴଴
(஺ೣశೌି஺ೣ)
  (2) 
where 𝐴௫ା௔ is optical density in the test with the 
test solution and with the solution of the 
Periciazine additive, 𝐴௫ - optical density in an 
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experiment with Periciazine test solution, С௔ −  
content of the Periciazine base in the solution of 
the additive mg/mL, 400 - dilution of 4% (40 
mg/mL) solution of the preparation. 
Results and discussion 
A study of the kinetics of the reaction by 
the method of iodometric titration of an 
oxidizing agent showed that in an acidic medium 
(0.001-0.01 mol L-1 HCl or H2SO4) at a 
temperature of 15-25°C, Periciazine is oxidized 
almost instantly (observation time 1 min). One 
mole of Periciazine consumes one mole of 
oxidizing agent, which indicates the formation 
of sulfoxide. Fig. 2 shows the UV absorption 
spectra of S-oxidation products of Periciazine in 
a solution of 0.02 mol L-1 HCl at a change in its 
concentration from 5 to 40 μgmL-1, obtained 
with 1·10-3 mol L-1 KHSO5.As can be seen, an 
oxidation product is observed, characterized by 
a band with a maximum at 362 nm. Proceeding 
from the literature, the chemistry of the process 
can be represented by the scheme (Fig. 3) 
 
Figure 2. UV spectra of light absorption of S-oxidation 
product of Periciazine. 0.02 mol L-1 HCl. C, μgmL-1:1-5; 
2 - 10; 3 - 20; 4 to 30; 5–40; UV absorption spectra of 
unoxidized Periciazine, 0 - 20,μgmL-1 
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Figure 3. Scheme of S-oxidation reaction of potassium 
Periciazine with hydrogen peroxymonosulfate in acidic 
medium 
The reaction product – the corresponding 
sulfoxide – is stable over time (the optical density 
at a given acidity did not change with the 
observation time 2 hours). The optical density of 
solutions at the maximum of light absorption is a 
linear function of the concentration of the 
derivative phenothiazine (the equation has the 
form  
A=(0.015±0.0005).·C characterized with 
correlation coefficient of 0.999) (Fig. 4). 
According to the calibration graph, the 
limit of detection (LOD) and the limit of 
quantification (LOQ) were calculated to be 
0.9 μgmL-1 and 2.8μgmL-1, respectively. 
 
 
Figure 4. Concentration dependence of light absorption of 
oxidation product (calibration graph for quantitative 
determination) of Periciazine 
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 Tables 1 and 2 show results obtained 
from determination of Periciazine in 10 mg 
capsules, as well as 4% solution (drops) (40 
mgmL-1) of Periciazine using the novel 
methods. They testified that proposed method of 
analysis performance allows to determine the 
Periciazine in finished dosage forms with 
reliable accuracy. The RSD lower than 1.76% 
was calculated. The results are in good 
correspondence with the findings of the study of 
phenothiazine derivative in 10 mg capsules and 
40 mg mL-1 solutions (drops) in accordance with 
the recommended in European Pharmacopoeia 
(δ=<RSD). 
Determination of Periciazine in 10 mg 
capsules, as well as 4% solution for intravenous 
use in the presence of a number of inactive 
ingredients with a corresponding sulfoxide, 
obtained with potassium hydrogen 
peroxymonosulfate, is more sensitive, faster and 
less laboriousness compared to methods based 
on the formation of free radicals of 
phenothiazine, as well as a simpler than a HPLC 
techniquementioned in introduction. It should be 
noted that the technique developed by our 
scientific group allows to determine Periciazine 
in the presence of ascorbic acid without their 
prior separation. 
 
 
 
 
 
Table 1. Results of Quantitative Determination of 
Periciazine in Neuleptil® 10 mg capsules 
Taken for analysis 
of the drug 
Found 
contents 
Metrological 
characteristi
cs 
mg/capsul
e 
Р=0.95 
0.1500 g 
(10.07 mg in one 
capsule)*Neulepti
l® 10 mg 
Capsules- № 5, 
SANOFI 
FamarellaChea 
Services Madrid 
S.A.U., Spain 
10.23 
10.40 
9.88 
10.06 
9.95 
10.15 
10.01 
 
x =10.10 
S=0.1779 
S
x
=0.0673 
x =0.1648 
RSD=1.76 
% 
δ*=+ 0.27 
% 
Notes: * Calculated according to the certificate of 
analysis; δ=( x -a)100/a; a - the content specified 
on the certificate.. Limits: 9.5 - 10.5 mg 
Periciazine / 1 caps. (95 - 105%). 
 
Thus, for the first time, in the practice of 
pharmaceutical analysis the method for indirect 
spectrophotometric determination of 10-
piperidyl alkyl derivatives of phenothiazine on 
the example of Neuleptil in pharmaceutical 
preparations based on reactions of peroxyacid S-
oxidation was proposed. 
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Table 2. Results of Quantitative Determination of 
Periciazinein 30 mL of 4% Neuleptilsolution 
Notes: * Calculated according to data on 
certificate (HPLC). δ=( x -a)100/a; a - the content 
specified on the certificate. 
 
Conclusions 
A completely new spectrophotometric 
procedures were developed for quantitative 
determination of Periciazine in pharmaceutical 
preparations. The common excipients employed 
do not interfere in the determination of 
phenothiazine drug. Results of analysis of the 
drug dosage forms by the proposed method are 
in good agreement with those of the official 
method. 
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